home

clinical

iol-advances

Articles

The company will begin commercialization of the IC-8 small aperture IOL, used for cataract patients, upon successful completion of the manufacturing facility inspections and receipt of an official approval order from the FDA, which the company estimates in Q2 2022. 

AcuFocus receives Approvable Letter from FDA for small aperture IOL 

The approval will allow LensGen to move forward with the IDE pivotal trial with the ultimate goal of seeking premarket approval in the United States. 

LensGen receives IDE approval from FDA to start study of Juvene presbyopia-correcting IOL 

Ribeiro is head of the Ophthalmology Department at Hospital da Luz in Lisbon, Portugal. This study was funded by a research grant from Johnson & Johnson Vision; she has no other financial relationships to disclose.

Lens combines diffractive multifocal and extended depth-of-focus properties.

New presbyopia-correcting IOL provides spectacle independence 

“Real talk” on new devices gives surgeons, patients decision-making insights

Physicians sort out pros and cons of several new IOLs on the market

Sustained-release option is deposited directly into the lenticular capsule.

Surgeons are changing delivery method

Yuen is in practice at Aloha Vision Consultants in Honolulu, Hawaii. He served as chairman of the Department of Ophthalmology at Kuakini Medical Center in Honolulu and chief of the Ophthalmology Division at Hawaii Medical Center West in Ewa Beach. He is a consultant for Johnson + Johnson Vision. 

Lens an option for complicated eyes, astigmatism, monovision candidates.

Depth-of-focus enhancement makes target easier to hit

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Early experience with next-generation lens engenders positive perception.

Presbyopia-correcting IOL improves vision for patients

IOL Advances

Videos

Edward Hu, MD, PhD, looked at  812 toric IOLs utilized of various platforms, concluding a low total toric rotation rate at 2.1%.


Retrospective study shows toric IOL rotation rate to be low at 2.1%

Beginning in the 1970s, James J. Salz, MD, was part of a group of ophthalmologists who first inserted intraocular lens implants during cataract surgery.

Ophthalmology pioneer James J. Salz, MD, dies at 82

The EVO/EVO+ Visian Implantable Collamer Lens provides visual freedom independent of contact lenses and glasses.
